Kamin Amends Psychemedics Stake Filing

TL;DR

Kamin updated his Psychemedics ownership filing (13D/A).

AI Summary

Peter H. Kamin, through an amendment filed on December 3, 2024, has updated his Schedule 13D filing regarding Psychemedics Corporation. This amendment, designated as Amendment No. 9, indicates a change in reporting or beneficial ownership of the company's common stock.

Why It Matters

Schedule 13D filings are crucial for investors as they disclose significant beneficial ownership changes, impacting stock price and investor sentiment.

Risk Assessment

Risk Level: medium — Schedule 13D filings often precede significant corporate actions or shifts in control, which can introduce volatility.

Key Numbers

• Amendment No. 9 — Filing Amendment (Indicates this is a significant update to previous filings.)
• December 3, 2024 — Date of Event (The date triggering the requirement for this amended filing.)

Key Players & Entities

• Peter H. Kamin (person) — Reporting person with updated beneficial ownership information.
• Psychemedics Corporation (company) — Subject company of the Schedule 13D filing.
• David E. Danovitch, Esq. (person) — Authorized person to receive notices and communications.
• Sullivan & Worcester LLP (company) — Legal counsel for the filing.

FAQ

Key Financial Figures

• $0.005 — ame of Issuer) Common Stock, par value $0.005 per share (Title of Class of Securiti

Filing Documents

• eps11668_kamin.htm (SC 13D/A) — 50KB
• ex99-5.htm (EX-99.5) — 34KB
• 0001171520-24-000386.txt ( ) — 85KB

Security and Issuer

Item 1. Security and Issuer. The information contained in “Item 1. Security and Issuer.” of the Schedule 13D is not being amended by this Amendment No. 9.

Identity and Background

Item 2. Identity and Background. The information contained in “Item 2. Identity and Background.” of the Schedule 13D is not being amended by this Amendment No. 9.

Source or Amount of Funds or Other Consideration

Item 3. Source or Amount of Funds or Other Consideration. The information contained in “Item 3. Source or Amount of Funds or Other Consideration.” of the Schedule 13D is not being amended by this Amendment No. 9.

Purpose of Transaction

Item 4. Purpose of Transaction. “Item 4. Purpose of Transaction.” of the Schedule 13D is being amended by this Amendment No. 9 to add the following: Repurchase Agreement On December 10, 2024, following the Issuer’s final determination of the funds required to purchase all of the fractional share interests that resulted from the reverse stock split based on information from the Issuer’s transfer agent, the Issuer repurchased 320,708 of such shares of Common Stock from 3K Limited at the same price 3K Limited paid to acquire shares in the Stock Sale, pursuant to a stock repurchase agreement (the “Repurchase Agreement”), dated December 10, 2024, by and between the Issuer and 3K Limited. SCHEDULE 13D/A CUSIP NO. 744375205 Page 4 of 5 The foregoing description of the Repurchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Repurchase Agreement, which is filed as Exhibit 99.5 to this Schedule 13D and incorporated herein by reference.

Interest in Securities of the Issuer

Item 5. Interest in Securities of the Issuer. "Item 5. Interest in Securities of the Issuer" of the Schedule 13D is being amemded and restated is by this Amendment No. 9 as follows: (a) The percentage ownership of shares of Common Stock set forth in this Amendment No. 9 is based upon 6,107,227 shares outstanding as of the close of business on December 11, 2024, which is the total number of shares outstanding as indicated to the Reporting Person by the Issuer. (b) The Reporting Person has the sole voting power and sole dispositive power with respect to all 1,736,741 shares of Common Stock held by him, the Trusts and 3K Limited. (c) Except as set forth in Item 4 of this Amendment No. 9 and in Amendment No. 8, the Reporting Person has not engaged in any transaction with respect to the Common Stock during the sixty days prior to the date of filing this Amendment No. 9. (d) Not Applicable. (e) Not Applicable.

Contracts, Arrangements, Understandings or Relationships

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. “Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.” of the Schedule 13D is being amended by this Amendment No. 9 to add the following: On December 10, 2024, 3K Limited and the Issuer entered into the Repurchase Agreement as described in Item 4 above and attached as Exhibit 99.5 hereto.

Material to be filed as Exhibits

Item 7. Material to be filed as Exhibits. “Item 7. Material to be filed as Exhibits.” of the Schedule 13D is being amended by this Amendment No. 9 to add the following exhibits: Exhibit Number* Description 99.5* Stock Repurchase Agreement, by and between Psychemedics Corporation and 3K Limited Partnership, dated December 10, 2024. * Filed as an exhibit herewith. SCHEDULE 13D/A CUSIP NO. 744375205 Page 5 of 5

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of his knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: December 12, 2024 /s/ Peter H. Kamin Peter H. Kamin

View Full Filing

View this SC 13D/A filing on SEC EDGAR